🔎 Trials Near Me

Akèy › Karsinòm selil skuamèz tèt ak kou › Lwizyàn

Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Lwizyàn

6 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan Lwizyàn.

Vil nan Lwizyàn

Tèks ofisyèl etid la (Anglè)

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

  • Ochsner Medical Center Jefferson, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06980038

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Tulane Cancer Center, New Orleans
  • Christus Highland/ Boniol, Shreveport
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05059444

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Touro Infirmary, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • Louisiana State University Health Sciences Center, New Orleans
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

  • Mary Bird Perkins Cancer Center, Baton Rouge
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Apr 9, 2026 · NCT06064877

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

  • LSU Health Sciences Center, Shreveport
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2025 · NCT06700070

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.